Angela M. Cacace, Chief Scientific Officer at Arvinas Inc. ($ARVN), sold shares on the open market four times over the past year, totaling about $118,000. Her most recent sale occurred on February 23, 2026. These transactions rank her 9,334th among 11,678 insiders by sale value, well below the average of 8.6 million per insider across 6.4 transactions. Cacace made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 73,400,000 | 9999.99% | 0.09% |
| Feb. 26, 2026 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 45000 | $0.00 | 192,623.0000 | 73,400,000 | 30.48% | 0.06% |
| Feb. 23, 2026 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 2571 | $12.16 | 147,623.0000 | 73,400,000 | 1.71% | 0.00% |
| Feb. 23, 2026 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 1038 | $12.16 | 150,194.0000 | 73,400,000 | 0.69% | 0.00% |
| Feb. 13, 2026 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 4592 | $11.89 | 151,232.0000 | 73,400,000 | 2.95% | 0.01% |
| June 17, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 2583 | $7.49 | 154,248.0000 | 68,800,000 | 1.65% | 0.00% |
| May 9, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 68,800,000 | 9999.99% | 0.13% |
| May 9, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 59600 | $0.00 | 156,831.0000 | 68,800,000 | 61.30% | 0.09% |
| Feb. 24, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 1146 | $16.55 | 97,231.0000 | 68,800,000 | 1.16% | 0.00% |
| Feb. 24, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | S | Common Stock | 3061 | $16.75 | 98,377.0000 | 68,800,000 | 3.02% | 0.00% |
| Feb. 13, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 74960 | $0.00 | 74,960.0000 | 68,800,000 | 9999.99% | 0.11% |
| Feb. 13, 2025 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 49092 | $0.00 | 100,944.0000 | 68,800,000 | 94.68% | 0.07% |
| June 17, 2024 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Common Stock | 15995 | $0.00 | 51,852.0000 | 68,000,000 | 44.61% | 0.02% |
| June 17, 2024 | ARVINAS, INC. | $ARVN | Cacace Angela M | Chief Scientific Officer | A | Stock Option (right to buy) | 24632 | $0.00 | 24,632.0000 | 68,000,000 | 9999.99% | 0.04% |